Janani R, Harris A W, Strasser A, Dhanoa S, Plyam R, Osmond D G
Department of Anatomy and Cell Biology, McGill University, Montreal, Quebec, Canada.
Exp Hematol. 1998 Sep;26(10):982-90.
Many B cell precursors die while differentiating in mouse bone marrow. To ascertain the mechanisms involved in this process, populations of B lineage cells and their tissue localization were analyzed in bone marrow of transgenic mice overexpressing the apoptosis inhibitor, Bcl-2. Immunofluorescence labeling and mitotic arrest were used to quantitate the number and proliferative activity of mu- pro-B cells (terminal deoxynucleotidyl transferase [TdT]+B220-, TdT+B220+, and TdT-B220+); pre-B cells (cmu+); and B cells (smu+). Mature B cells (IgM+IgD+) were increased 16- to 20-fold. In addition, immature B lymphocytes (IgM+IgD-/low), representing newly formed cells, were increased three- to sixfold, whereas pre-B cells and late pro-B cells were increased 30 to 60% in production rate. Earlier pro-B cells expressing TdT were unaffected. In spleen, both mature and immature B cells were greatly increased, but cells of precursor phenotype were few and TdT+ cells were absent. The in vivo location of B cells was examined by autoradiography using light and electron microscopy after intravenous injection of 125I-labeled antibodies. B lineage cells (B220+) were increased throughout bone marrow, often within dilated venous sinusoids, particularly in subosteal regions. Many intravascular and perisinusoidal cells were IgDhigh mature B lymphocytes. In contrast, many other IgM+ and IgDlow immature B lymphocytes clustered extravascularly around the central venous sinus. Plasma cells with distended endoplasmic reticulum were numerous. These findings provide evidence that, in addition to expanding the recirculating pool of B cells entering bone marrow from the blood stream, high levels of Bcl-2 can inhibit some of the apoptosis occurring during B cell differentiation, thereby expanding populations of B lymphopoietic precursor cells within the bone marrow parenchyma.
许多B细胞前体在小鼠骨髓中分化时死亡。为了确定这一过程中涉及的机制,我们分析了过表达凋亡抑制剂Bcl-2的转基因小鼠骨髓中B系细胞群体及其组织定位。采用免疫荧光标记和有丝分裂阻滞法对μ原B细胞(末端脱氧核苷酸转移酶[TdT]+B220-、TdT+B220+和TdT-B220+)、前B细胞(cmu+)和B细胞(smu+)的数量和增殖活性进行定量。成熟B细胞(IgM+IgD+)增加了16至20倍。此外,代表新形成细胞的未成熟B淋巴细胞(IgM+IgD-/低)增加了3至6倍,而前B细胞和晚期原B细胞的产生率增加了30%至60%。表达TdT的早期原B细胞未受影响。在脾脏中,成熟和未成熟B细胞均显著增加,但前体表型的细胞很少,且不存在TdT+细胞。静脉注射125I标记抗体后,通过光镜和电镜放射自显影检查B细胞的体内位置。B系细胞(B220+)在整个骨髓中均有增加,常位于扩张的静脉窦内,尤其是在骨膜下区域。许多血管内和窦周细胞是IgD高的成熟B淋巴细胞。相比之下,许多其他IgM+和IgD低的未成熟B淋巴细胞在血管外围绕中央静脉窦聚集。内质网扩张的浆细胞数量众多。这些发现提供了证据,表明高水平的Bcl-2除了扩大从血流进入骨髓的循环B细胞池外,还可以抑制B细胞分化过程中发生的一些凋亡,从而扩大骨髓实质内的B淋巴细胞前体细胞群体。